Does higher SHBG reduce free and bioavailable testosterone and lower tissue androgen exposure?

Sex hormone-binding globulin (SHBG) is the primary transport glycoprotein synthesized by the liver that regulates the distribution of testosterone in circulation. In aging men, SHBG levels characteristically rise, which profoundly alters the balance of active male sex hormones.

Clinical and physiological evidence

• Affinity and distribution: Approximately 40% to 60% of circulating testosterone is bound tightly to SHBG, while the remainder is weakly bound to albumin or exists as unbound (free) testosterone. Only the free and albumin-bound fractions are considered "bioavailable."
• Aging and hormone shift: Longitudinal clinical studies indicate that SHBG levels rise by approximately 1% to 1.5% per year in aging men. Consequently, even when total testosterone levels remain stable, the free and bioavailable fractions decrease progressively over time, leading to clinical symptoms of androgen deficiency.
• Negative feedback mechanisms: Lower free testosterone levels, rather than total testosterone, modulate the hypothalamic-pituitary-gonadal axis, driving compensatory changes in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.

Mechanistic explanations

• The Free Hormone Hypothesis: Only the free and weakly albumin-bound fractions of testosterone can diffuse across lipid bilayers to bind to intracellular androgen receptors.
• Tissue-level restriction: Transgenic animal models expressing human SHBG show that elevated SHBG physically traps testosterone within the vascular space, preventing cellular entry. In these models, higher SHBG directly reduces androgen receptor signaling and limits androgenic action in target organs such as the prostate and skeletal muscle, even when total systemic testosterone is elevated.

Bottom line

• Elevated SHBG levels directly reduce the bioavailable testosterone fraction. This limits cellular diffusion and decreases androgen receptor activation at the tissue level, making SHBG a critical determinant of functional androgen status in aging men.